Clinical Trial Update: Nicotinic Modulation of Schizophrenia-like Information Processing Deficits in Healthy Subjects [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating how nicotinic modulation affects schizophrenia-like information processing deficits in healthy subjects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: Yale University | Conditions: Healthy Subjects | Phase 1 | Status: COMPLETED